|
|
On
September 30, 2004, the international prescription
drug company Merck announced the worldwide withdrawal
of the arthritis medication Rofecoxib, sold
in most countries under the brand name Vioxx,
because a study showed an increased risk of
heart attack and stroke. Patients who have suffered
injuries due to Vioxx have filed litigation
against Merck for failing to recall the drug
when it first learned of Vioxx's dangerous side
effects.
To contact in confidence an experienced personal
injury attorney at Lieff Cabraser working on
the Vioxx lawsuit, click
here. |
|
|
|
|
|
The
painkiller Vioxx was marketed throughout the
world, sold in many countries under the name
Vioxx and in others as Ceoxx. Lieff Cabraser
is working with attorneys and solicitors in:
Argentina
 Austria
Canada
Ireland
Italy
South Africa
United
Kingdom
and other countries to bring litigation against
Merck in U.S. courts for patients suffering
heart attacks and strokes from Vioxx. If you
are visiting this website from outside the U.S.,
please click here
to contact an attorney regarding your experiences
with Vioxx or Ceoxx. |
|
|
|
| |
|
Lieff
Cabraser's
Competitive Advantages
|
|
|
| Lieff
Cabraser Heimann & Bernstein, LLP is a national plaintiffs’
law firm with offices in San Francisco, New York, Washington,
D.C., Beverly Hills and Nashville. |
| We
have a team of partners, associates, legal assistants and
nurses with years of experience in injury cases who are
dedicated to advancing our clients’ interests. We believe
we offer our clients the following advantages: |
| Premier
National Reputation |
| With
nearly 60 lawyers in five offices, Lieff Cabraser is among
the largest law firms in the United States that represents
only plaintiffs. Our firm enjoys a national reputation for
professional integrity and the efficient and responsible
prosecution of our clients’ claims. We possess sophisticated
legal skills and the financial resources necessary for the
handling of complex cases. |
| We
are proud that the successes of our firm have repeatedly
been recognized by independent publications. In 2003 and
2004, the National Law Journal selected our firm
as one of the top 20 plaintiffs’ law firms in the nation.
Elizabeth J. Cabraser has repeatedly been recognized by
the National Law Journal as one of the top attorneys
in the United States. In 2004, The Corporate Legal Times
named Ms. Cabraser to its list of the five best plaintiffs’
attorneys in America. In 2002, Steven E. Fineman, the Managing
Partner of Lieff Cabraser, was selected by the National
Law Journal as one of the nation’s most successful
young litigators. |
| Landmark
Recoveries |
| Since
1992, Lieff Cabraser has litigated 23 separate cases in
which $100 million or more in jury verdicts were rendered
or settlements were reached, including 11 cases valued at
$1 billion or more. We have successfully represented clients
across America in many of the most prominent personal injury
and products liability cases in the U.S. over the past decade. |
| For
example, the United States District Court appointed us to
the Plaintiffs’ Management Committee to organize and
direct all Fen-Phen cases filed in federal court. The case
resulted in a $4.75 billion class action settlement that
received final judicial approval in 2002. Since the recall
of Fen-Phen in 1997, we have represented hundreds of patients
in individual lawsuits who have developed serious illnesses
including primary pulmonary hypertension and heart valve
damage. We continue to dedicate substantial resources to
our Fen Phen clients and are available for confidential
consultations with anyone who ingested these drugs, sold
as Redux and Pondimin. |
| Experienced
Trial Attorneys |
| We
vigorously litigate the rights of our clients, bringing
claims to trial when necessary to achieve justice. Already
this year, Lieff Cabraser attorneys commenced trial in three
separate courts across America. |
| Currently,
we are prosecuting multiple cases involving catastrophic
injuries and death claims claims for clients injured, or
the families of loved ones who have died, by unsafe
sports utility vehicles, pickup
trucks, 15-passenger
vans and heavy
trucks. In the 15-passenger van and SUV lawsuits, plaintiffs
allege that the vehicles were defectively designed because
they pose an unreasonable risk of rolling over during foreseeable
driving conditions. We also represent clients in several
other individual vehicle injury lawsuits, including personal
injury lawsuits based on allegations that certain models
of the Jeep
Grand Cherokee are defectively designed because the
vehicle can shift suddenly from park into reverse, even
when the engine is not running. |
| Recent
trials by Lieff Cabraser that have received widespread media
attention include the following: |
- In
re Tri-State Crematory. On March 1, 2004, trial
began in federal court in Georgia on behalf of the bereaved
families whose relatives’ bodies were desecrated
or improperly cremated by the Tri-State Crematory in
Noble, Georgia. The lawsuit sought damages from Tri-State
Crematory and the funeral homes with which it did business.
One week into trial, settlements were reached with all
funeral home defendants and brought the settlement total
to approximately $37 million. The Marsh defendants,
the operators of Tri-State Crematory, however, withdrew
from the tentatively approved settlement. Trial on the
class members' claims against the Marsh defendants began
in August 2004. Soon thereafter, the Marsh defendants
entered into a $80 million settlement with plaintiffs.
As part of the settlement, all buildings on the Tri-State
property will be razed. Lieff Cabraser served as co-lead
trial counsel, with partners Elizabeth Cabraser and
Kathryn E. Barnett leading the trial team. Ms. Barnett
gave theng statement for plaintiffs.
- Claghorn
v. Edsaco. In April 2002, a federal jury returned
a $170.7 million verdict in an investor fraud case in
favor of the plaintiffs. Richard M. Heimann of Lieff
Cabraser conducted the trial for plaintiffs. Following
the Edsaco trial, the parties reached a settlement of
the action on favorable monetary terms to the class,
which included Edsaco’s relinquishment of its right
to appeal and the plaintiffs' agreement to vacate the
jury verdict. Commenting on Lieff Cabraser’s trial
work, the Judge stated:
“[C]ounsel for the plaintiffs did a very good job
in a very tough situation of achieving an excellent
recovery for the class here. You were opposed by extremely
capable lawyers. It was an uphill battle. There were
some complicated questions, and then there was the tricky
issue of actually collecting anything in the end. .
. [T]he recovery that was achieved for the class in
this second trial is remarkable, almost a hundred percent.”
|
| Individual
Attention and a Wealth of Resources for Each Client |
| Providing
superior service to our clients and working closely with
our clients throughout every stage of the litigation is
fundamental to how our firm operates. Each client is assigned
a partner and an associate to see his or her case through
to resolution. |
| In
addition, we have on staff a team of nurses, legal assistants
and a scientific advisor, all experienced in personal injury
lawsuits. We also have relationships with top experts in
the fields of medicine, surgery, pharmacology, automotive
safety, industrial safety, aviation, product design and
accident and disaster reconstruction. |
| Advancing
the Interests of our Client is Paramount |
| Once
we accept a personal injury case, we zealously pursue as
favorable a settlement or recovery at trial for our clients
as permitted under the law. We are committed to bringing
all of our resources to bear to ensure justice for our clients. |
| The
leadership we displayed in the Sulzer hip and knee litigation
is characteristic of our determination and tenacity in advancing
our clients’ interests. In December 2000, Sulzer Orthopedics,
Inc., recalled almost 30,000 hip implants. Almost a year
later, Sulzer announced that it had reached an approximately
$700 million settlement with certain plaintiffs’ counsel.
Utilizing our financial expertise to evaluate the insurance
policies and other assets available to Sulzer, we strongly
objected to the settlement proposed by Sulzer. Subsequently,
we helped negotiate a revised settlement with Sulzer valued
at more than $1 billion which the court approved in May
2002. |
| Lieff
Cabraser: Experienced Product Liability Lawyers |
| Founded
in 1972, Lieff Cabraser Heimann & Bernstein, LLP is
a nearly sixty attorney law firm with offices in San Francisco,
New York, Washington, D.C., Beverly Hills, and Nashville.
In 2003 and 2004, the National Law Journal recognized
Lieff Cabraser as one of the top 20 plaintiffs’ law
firms in America. |
| For
our personal injury cases, we bring a team of experienced
lawyers. Each client is assigned a partner and an associate.
In addition, we have on staff multiple nurses, legal assistants,
scientific analysts and case clerks to assist the attorneys.
|
| We
have represented thousands of patients who ingested prescription
drugs with dangerous undisclosed side effects, and patients
who received defective medical devices in personal injury
lawsuits across America, including residents of Alaska,
Alabama, Arkansas, Arizona, California, Colorado, Connecticut,
Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana,
Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine,
Michigan, Minnesota, Missouri, Montana, North Carolina,
North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico,
Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania,
Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia,
Vermont, Washington, Wisconsin, West Virginia and Wyoming. |
| We
look forward to communicating with you and answering any
questions you may have. To learn more about the competitive
advantages our firm offers clients in personal injury and
products liability cases, click
here. |
| Contact
Lieff Cabraser |
| To
contact a Lieff Cabraser attorney experienced in personal
injury litigation, please click here.
There is no charge or obligation for our review of your
claim. |
|
| Note:
This summary of our personal injury and trial experience
is for informational purposes only and does not and cannot
constitute legal advice. The determination of the need for
legal services and the choice of a lawyer are extremely
important decisions that should not be based solely upon
advertisements or self-proclaimed expertise. Before you
decide to retain us, ask us to send you free written information
about our qualifications and experience. Lieff Cabraser
does not offer any guarantee of case results. Please read
our disclaimer. |
|
|
|
|
|
Lieff
Cabraser Heimann & Bernstein, LLP
|
|
|
|
|
|
|
| Trademark
Notice |
| "Vioxx"
is a registered trademark of Merck. Lieff Cabraser Heimann
& Bernstein, LLP is in no way affiliated with Merck,
and the Vioxx trademark is used solely for informational
purposes. |
|
|
|
Copyright
© 2004-2005 Lieff Cabraser Heimann & Bernstein,
LLP
|
| |
|
|
"Banned
Report on Vioxx Published" Los Angeles
Times, Jan. 25, 2005
A report on Vioxx risks previously blocked by
the FDA was published online Monday after the
agency withdrew its opposition. The study found
that as many as 140,000 cases of heart disease
in the United States and as many as 56,000 deaths
were caused by the painkiller Vioxx during the
five years that it was on the market.
To read more press articles on the Vioxx recall
and Vioxx class action lawsuit, click
here. |
|
|
|
|
|
| Lieff
Cabraser has participated in twenty-three $100
million-plus settlements and verdicts. To read
a summary, click here. |
|
|
|
|
|
Click here to read
recent press articles on the Vioxx recall and
Vioxx lawsuits. |
|
|
|
|
|
Read about key events in the Vioxx recall and
Vioxx lawsuit by clicking
here. |
|
|
|
|